Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:1029712-80-8
Molecular Formula:C23H17FN6O
Alias
More Information
Benzamide,2-Fluoro-N-Methyl-4-[7-(6-Quinolinylmethyl)Imidazo[1,2-B][1,2,4]Triazin-2-Yl]-; 2-Fluoro-N-Methyl-4-[7-[(Quinolin-6-Yl)Methyl]Imidazo[1,2-B]-[1,2,4]Triazin-2-Yl]Benzamide Capmatinib;
Brief Introduction
Camatinib can effectively inhibit the proliferation and migration of c-met dependent tumor cells and induce apoptosis. It has antitumor activity.
CAS:128607-22-7
Molecular Formula:C24H23ClO2
Alias
More Information
2-[4-[(1Z)-4-Chloro-1,2-Diphenyl-1-Buten-1-Yl]Phenoxy]-Ethanol; 2-(P-((Z)-4-Chloro-1,2-Diphenyl-1-Butenyl)Phenoxy)Ethanol; Ccris 9205; Fc-1271A; Ospemifene; Unii-B0P231Ilbk; 2-[4-[(Z)-4-Chloro-1,2-Diphenylbut-1-Enyl]Phenoxy]Ethanol
CAS:1393477-72-9
Molecular Formula:C17H11F6N7O
Alias
More Information
(2Z)-3-[3-[3,5-Bis(Trifluoromethyl)Phenyl]-1H-1,2,4-Triazol-1-Yl]-2-Propenoic Acid 2-(2-Pyrazinyl)Hydrazide; Selenixor; Selinexor; Selinexor (Kpt-330); (Z)-3-(3-(3,5-Bis(Trifluoromethyl)Phenyl)-1H-1,2,4-Triazol-1-Yl)-N'-(Pyrazin-2-Yl)Acrylohydrazide; 2-Propenoic Acid, 3-[3-[3,5-Bis(Trifluoromethyl)Phenyl]-1H-1,2,4-Triazol-1-Yl]-, 2-(2-Pyrazinyl)Hydrazide, (2Z)-; Aloradine; Kpt330,Selinexor
Brief Introduction
In July 2019, Celinosol (trade name: Xpovio) was approved for sale in the United States, becoming the world's first and only selective nuclear export inhibitor. Subsequently, Selinso was approved for listing in Israel, the United Kingdom, and EU countries.
CAS:317318-70-0
Molecular Formula:C21H18F3NO3S2
Alias
More Information
GW501516; GW 501516; GW-501516; GSK-516; Cardarine; GW1516; GW 1516; GW-1516; 2-(4-((2-(4-(Trifluoromethyl)Phenyl)-4-Methylthiazol-5-yl)Methylthio)-2-Methylphenoxy)Acetic acid; 2-(2-Methyl-4-(((4-Methyl-2-(4-(Trifluoromethyl)Phenyl)Thiazol-5-yl)Methyl)thio)Phenoxy)Acetic acid; 2-[2-Methyl-4-[[4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-1,3-Thiazol-5-yl]Methylsulfanyl]Phenoxy]Acetic acid; GW-516; {2-Methyl-4-[({4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-1,3-Thiazol-5-yl}Methyl)Sulfanyl]Phenoxy}Acetic acid; 2-{2-Methyl-4-[({4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-1,3-Thiazol-5-yl}Methyl)Sulfanyl]Phenoxy}Acetic acid; GSK 516; 2-[2-Methyl-4-[[[4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-5-Thiazolyl]Methyl]thio]Phenoxy]Acetic Acid; Benzenesulfonylchloride,4-(2-Methylpropyl)-(9CI); (2-Methyl-4-(((4-Methyl-2-(4-(Trifluoromethyl)Phenyl)-1,3-Thiazol-5-YL)Methyl)THIO)Phenoxy)Acetic ACID; {2-Methyl-4-{{4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-5-Thiazolyl}Methylthio}Phenoxy}Acetic acid, Analytical Standard; {4-[({4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-1,3-Thiazol-5-yl}Methyl)Sulfanyl]-2-Methylphenoxy}Acetic acid; 2-(2-Methyl-4-((5-Methyl-2-(4-(Trifluoromethyl)Phenyl)Thiazol-4-yl)Methylthio)Phenoxy)Acetic acid;GW 501516; 2-{2-Methyl-4-[({4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-1,3-Thiazole-5-yl}Methyl)Sulfanyl]Phenoxy}Acetic acid; Acetic acid, (2-Methyl-4-(((4-Methyl-2-(4-(Trifluoromethyl)Phenyl)-5-Thiazolyl)Methyl)thio)Phenoxy)-; Acetic acid, 2-[2-Methyl-4-[[[4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-5-Thiazolyl]Methyl]thio]Phenoxy]-
Brief Introduction
Endurobol is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s, was entered into clinical development as a drug candidate for metabolic diseases and cardiovascular diseases, and was abandoned in 2007 because animal testing showed that the drug caused cancer to develop rapidly in several organs.
CAS:58579-51-4
Molecular Formula:C10H8Cl3N3O
Alias
More Information
Anagrelide HCL; Agrylin; Agrelin; Thromboreductin; Xagrid; Anagrelide (Hydrochloride); Anagrelid Hydrochlorid; 6,7-Dichloro-5,10-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)-Quinazolin-2(3H)-one Monohydrochloride; Anagrelide Hydrochloride Hydrate; Xagrid (TN); Imidazo(2,1-b)Quinazolin-2(3H)-one, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-3,5-Dihydro-1H-Imidazo[2,1-b]Quinazolin-2-one;Hydrochloride; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one;Hydrochloride; C10H7Cl2N3O.ClH; Imidazo[2,1-b]Quinazolin-2(3H)-one, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride; Anagrelide Hydrocholoride; C10H7Cl2N3O.HCl; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one Hydrochloride; Anagrelide Hydrochloride (USP); Anagrelide Hydrochloride- Bio-X; 6,7-Dichloro-1H,2H,3H,5H-Imidazolidino[2,1-b]Quinazolin-2-one Hydrochloride; Anagrelide Hydrochloride Anhydrous; Imidazo[2,6,7-Dichloro-1,5-Dihydro-, Monochloride; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one HCl; 6,7-Dichloro-2H,3H,5H,10H-Imidazo[2,1-b]Quinazolin-2-one Hydrochloride; 6,7-Dichloro-3,5-Dihydroimidazo[2,1-b]Quinazolin-2(1H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-.BETA.)-Quinazolin-2(3H)-ONE Monohydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)-Quinazolin-2(3H)-one Monohydrochloride ; 6,7-Dichloro-1,5-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Monohydrochloride;Anagrelide Hydrochloride; Imidazo(2,1-.BETA.)Quinazolin-2(3H)-ONE, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride
Brief Introduction
Anagrelide Hydrochloride is a phosphodiesterase inhibitor with antiplatelet activity. Used as an antithrombocythemic.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!